As Congress mulls whether to follow President Donald Trump’s orders for a most-favored-nation drug-pricing policy, biotech firm executives are starting to speak out against the measure.

A key focus of Indra’s presentation will be its next-generation free-flow tolling system, which removes traditional roadside infrastructure that requires vehicles to slow down or stop. Instead of ...